Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Sideri

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Journal of Lower Genital Tract Disease|October 19, 2016
Prevalence and Risk Factors of Human Papillomavirus Infection in 18-Year-Old Women: Baseline Report of a Prospective Study on Human Papillomavirus VaccineSarah Igidbashian, Sara Boveri, Fabio Bottari, et al.
BMC Health Services Research|July 2, 2013
Rationale and development of an on-line quality assurance programme for colposcopy in a population-based cervical screening setting in ItalyLauro Bucchi, Paolo Cristiani, Silvano Costa, et al.
BMC Infectious Diseases|October 26, 2013
Comparison of the performance of carcinogenic HPV typing of the Roche Linear Array and Qiagen LiquiChip® HPV assaysPhilippe Halfon, Maria Teresa Sandri, Audrey Raimondo, et al.
Epidemiologia E Prevenzione|November 10, 2012
[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening]Guglielmo Ronco, Massimo Confortini, Vincenzo Maccallini, et al.
Archives of Virology|January 10, 2013
HPV genotype distribution according to severity of cervical neoplasia using the Digene HPV genotyping LQ testPhilippe Halfon, Maria Luisa Mateos Lindemann, Audrey Raimondo, et al.
Journal of Clinical Microbiology|June 8, 2006
Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samplesMaria T Sandri, Paola Lentati, Elvira Benini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16Uzma A Hasan, Elizabeth Bates, Fumihiko Takeshita, et al.
Infectious Agents and Cancer|November 1, 2012
HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studiesPaolo Giorgi Rossi, Mario Sideri, Francesca Maria Carozzi, et al.
Cancer Chemotherapy and Pharmacology|September 12, 2014
Prognostic value of human papillomavirus in anal squamous cell carcinomaPaola Simona Ravenda, Elena Magni, Edoardo Botteri, et al.
Archives of Gynecology and Obstetrics|August 10, 2016
Chlamydia trachomatis infection and HPV/Chlamydia trachomatis co-infection among HPV-vaccinated young women at the beginning of their sexual activitySilvia Bianchi, Sara Boveri, Sarah Igidbashian, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Journal of Lower Genital Tract Disease|October 19, 2016
Prevalence and Risk Factors of Human Papillomavirus Infection in 18-Year-Old Women: Baseline Report of a Prospective Study on Human Papillomavirus VaccineSarah Igidbashian, Sara Boveri, Fabio Bottari, et al.
BMC Health Services Research|July 2, 2013
Rationale and development of an on-line quality assurance programme for colposcopy in a population-based cervical screening setting in ItalyLauro Bucchi, Paolo Cristiani, Silvano Costa, et al.
BMC Infectious Diseases|October 26, 2013
Comparison of the performance of carcinogenic HPV typing of the Roche Linear Array and Qiagen LiquiChip® HPV assaysPhilippe Halfon, Maria Teresa Sandri, Audrey Raimondo, et al.
Epidemiologia E Prevenzione|November 10, 2012
[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening]Guglielmo Ronco, Massimo Confortini, Vincenzo Maccallini, et al.
Archives of Virology|January 10, 2013
HPV genotype distribution according to severity of cervical neoplasia using the Digene HPV genotyping LQ testPhilippe Halfon, Maria Luisa Mateos Lindemann, Audrey Raimondo, et al.
Journal of Clinical Microbiology|June 8, 2006
Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samplesMaria T Sandri, Paola Lentati, Elvira Benini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16Uzma A Hasan, Elizabeth Bates, Fumihiko Takeshita, et al.
Infectious Agents and Cancer|November 1, 2012
HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studiesPaolo Giorgi Rossi, Mario Sideri, Francesca Maria Carozzi, et al.
Cancer Chemotherapy and Pharmacology|September 12, 2014
Prognostic value of human papillomavirus in anal squamous cell carcinomaPaola Simona Ravenda, Elena Magni, Edoardo Botteri, et al.
Archives of Gynecology and Obstetrics|August 10, 2016
Chlamydia trachomatis infection and HPV/Chlamydia trachomatis co-infection among HPV-vaccinated young women at the beginning of their sexual activitySilvia Bianchi, Sara Boveri, Sarah Igidbashian, et al.
Pageof 5